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Two hereditary syndromes, lymphedema-distichiasis (LD) syn-
drome and blepharo-chelio-dontic (BCD) syndrome include the
aberrant growthof eyelashes from themeibomianglands, known
asdistichiasis. LD is anautosomaldominant syndromeprimarily
characterized by distichiasis and the onset of lymphedema
usually during puberty. Mutations in the forkhead transcription
factor FOXC2 are the only known cause of LD. BCD syndrome
consists of autosomal dominant abnormalities of the eyelid, lip,
and teeth, and the etiology remains unknown. In this report, we
describe a proband that presented with distichiasis, microceph-
aly, bilateral grade IV vesicoureteral reﬂux requiring ureteral
re-implantation, mild intellectual impairment and apparent
glomuvenous malformations (GVM). Distichiasis was present
in three generations of the proband’smaternal side of the family.
The GVMs were severe in the proband, and maternal family
members exhibited lower extremity varicosities of variable de-
gree. A GLMN (glomulin) gene mutation was identiﬁed in the
proband that accounts for the observed GVMs; no other family
member couldbe tested.TIE2 sequencing revealednomutations.
In the proband, an additional submicroscopic 265 kb contiguous
gene deletion was identiﬁed in 16q24.3, located 609 kb distal to
theFOXC2 locus,whichwas inherited from the proband’smother.
The deletion includes the C16ORF95, FBXO31,MAP1LC3B, and
ZCCHC14 loci and 115 kb of a gene desert distal to FOXC2 and
FOXL1. Thus, it is likely that the microcephaly, distichiasis,
vesicoureteral, and intellectual impairment in this family may
be caused by the deletion of one or more of these genes and/or
deletion of distant cis-regulatory elements ofFOXC2 expression.
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INTRODUCTION
Distichiasis is deﬁned as a second row of eyelashes arising from the
meibomian glands of the eyelid [Brooks et al., 2003]. Distichiasis
can be inherited in an autosomal dominant manner as part
of lymphedema-distichiasis syndrome (LD; OMIM 153400) or
blepharo-chelio-dontic syndrome (BCD; OMIM 119580). LD is
characterized by onset of bilateral lower limb lymphedema at
puberty and congenital distichiasis, as well as other less penetrant
clinical associations including varicose veins, congenital heart
disease, cleft palate, and ptosis [Fang et al., 2000; Bell et al.,
2001; Erickson et al., 2001; Finegold et al., 2001; Brice et al.,
2002]. FOXC2mutations cause the majority of LD cases, although
two LD families without FOXC2mutations but with linkage to the
FOXC2 region have been reported [Sholto-Douglas-Vernon et al.,
2005]. Diagnostic criteria for BCD syndrome includes abnormali-
ties of the eyelid (euryblepharon, ectropion of lower lid, distichiasis
of the upper lid, lagophthalmia), lip (bilateral cleft lip and palate)
and teeth (oligodontia and microdontia)[Gorlin et al., 1996]. To
date, the molecular cause of BCD is unknown.
Vascular malformations are congenital lesions that exhibit a
normal rate of endothelial cell proliferation, but result from inborn
errors of vascular morphogenesis [Mulliken, 1988]. Vascular mal-
formations are classiﬁed based on the affected vessel-type (artery,
vein, capillary) and ﬂow-characteristics (fast or slow) into venous
malformations (VM), capillary malformations and arterial mal-
formations. Some genetic factors responsible for vascular malfor-
mations have been elucidated [for review Brouillard and Vikkula,
2007]. Most VM are sporadic, but some hereditary VM exhibit
autosomal dominant inheritance [Boon et al., 2004]. Cutaneomu-
cosal venous malformations (VMCM) are composed of dilated
vessels with thin walls and poor smooth muscle cell coverage
[Vikkula et al., 1996; Boon et al., 2004]. Linkage analysis led to
the identiﬁcationofmutations in the receptor tyrosine kinaseTIE-2
(TEK) gene as the cause of VMCM [Vikkula et al., 1996]. Glomu-
venous malformations (GVM) are vascular anomalies character-
ized by venous-like channels surrounded by abnormal smooth
muscle-like cells known as glomus cells [Boon et al., 2004].
GLMN gene mutations were identiﬁed as the cause of GVMs
[Brouillard et al., 2002, 2005].
Here, we report on a case that presented with distichiasis,
microcephaly, bilateral grade IV vesicoureteral reﬂux, mild intel-
lectual impairment, and GVMs. No lymphedema had developed
in the proband and no FOXC2 coding exon mutations were
detected. Clinical chromosomal microarray analysis identiﬁed a
16q24.3 submicroscopic contiguous gene deletion including the
C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci. The dele-
tion was further characterized by ﬂuorescent in situ hybridization
(FISH), and the breakpoints were identiﬁed and sequenced. There
were 2 bp of homology at the breakpoints, suggesting the deletion
was formed by a non-homologous end joining (NHEJ) or template
switching mechanism. Further genetic testing of known VM gene
candidates revealed that the probandwas heterozygous for a known
pathogenic 157delAAGAA GLMN mutation [Brouillard et al.,
2002, 2005]. The 16q24.3 deletion may be a novel cause of a rare
if not unique syndrome including distichiasis, microcephaly, bilat-
eral grade IV vesicoureteral reﬂux, and intellectual impairment due
to position effect on FOXC2 and/or deletion of one or more distal
genes.
MATERIALS AND METHODS
Ascertainment
The proband was referred to the University of Michigan Pediatric
Genetics Clinic for evaluation of a potential vascular malformation
syndrome and was evaluated by one of the authors (J.W.I.). The
presence of distichiasis suggested that features of the proband may
be caused by a FOXC2mutation. Therefore, informed consent for
DNAtestingwasobtained fromtheprobandand familymembers in
accordance with the guidelines of the University of Michigan
Medical School Institutional Review Board.
MR Imaging
Imaging was performed on a 1.5 T MR (Sigma, GE Healthcare,
Waukesha, WI). The MR images in Figure 3 were obtained
under the following conditions: 3A-axial T1-weighted (TR
467ms, TE 14ms), 3B-Axial T2-weighted (TR 3,400ms, TE
79ms), 3C-Coronal short tau inversion recovery (TR 4,000ms,
TE 26.2ms, TI 165ms), 3D-Axial T1-weighted with fat saturation
post-gadolinium (TR210ms, TE 3.5ms), 3E-Coronal T1-weighted
with fat saturation post-gadolinium (TR 255ms, TE 3.3ms).
DNA Isolation and Establishment of the LD-064
Cell Line
Genomic DNA was extracted from 5ml blood samples using a
guanidine HCl method for DNA extraction from blood [Ciulla
et al., 1988]. The LD-064 cell line was established from a 5ml blood
sample fromtheprobandusing the lymphocyte separationmedium
(ICN, Aurora, OH) and immortalization with Epstein–Barr virus
(EBV) [Gilbert, 2001].
FOXC2, Glomulin, and TIE2 Mutation Screening
FOXC2 was screened for mutations as previously described [Fang
et al., 2000]. Deletion of the FOXC2 locus was tested for by FISH
using BAC clone RP11-463O9 as probe. Sequencing of the GLMN
and TIE2 genes was carried out as described [Vikkula et al., 1996;
Brouillard et al., 2002].
Chromosomal Analysis
The proband’s karotype was evaluated by the University of Mich-
igan Clinical Cytogenetics Laboratory. Genomic microarray anal-
ysis using a BAC array (v4.1) was performed onDNA samples from
the proband, the brother and mother of the proband at Baylor
College of Medicine.
FISH
BAC clones RP11-463O9, RP11-235F18, RP11-178L8, RP11-
482M8, RP11-264L1 were purchased from CHORI BACPAC Re-
source Center (Oakland, CA). FISH probes were generated using
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the Roche Biotin Nick Translation Kit (Indianapolis, IN) with 1mg
BAC DNA. FISH was performed as previously described [Wilke
et al., 1996].
SNP Genotyping
SNPs surrounding the 16q24.3 deletionwere chosen for genotyping
using the UCSC genome browser and dbSNP [Sherry et al., 2001;
Karolchik et al., 2003]. Primers for PCR were designed using
Primer3 to ﬂank the SNPs of interest [Rozen and Skaletsky,
2000]. All primers are listed in Table I. All PCRs were performed
with Invitrogen Taq polymerase (Carlsbad, CA) using standard
conditions (20mM Tris–HCl pH 8.4, 50mM KCl, 1.5mMMgCl2,
0.2mM dNTPs, 0.2mM each sense and antisense primers) with a
60Cannealing temperature and an extensionof 1min for 30 cycles.
PCR products were separated by gel electrophoresis and subse-
quently puriﬁed with the Zymoclean gel DNA recovery kit (Zymo
Research; Orange, CA). PCR products were sequenced by the
University of Michigan DNA Sequencing Core (http://seqcore.
brcf.med.umich.edu/).
Inverse PCR
Inverse PCR was performed as previously described [Wei et al.,
2001;Morrish et al., 2002]. Primers located distal to rs4843612were
chosen for inverse PCR using Primer3 [Rozen and Skaletsky, 2000].
Genomic DNA (5mg) from the proband were digested with SspI,
SphI, PstI, or HindIII and circularized with 3,200 units of T4 DNA
Ligase from NEB (Ipswich, MA) in a ﬁnal volume of 1ml. The
resulting ligation products were PCR-ampliﬁed using primers
Inverse-F (50-TTACGCATGCTGTTTGGAAA-30) and Inverse-R
(50-TGTGGTTTTGCCCTGGTCTT-30). PCR conditions were as
follows: initial cycle of 95Cfor 5min, followedby35 cycles of 30 sec
at 94C, 30 sec at 60C, 15min at 68C, with a ﬁnal step of 68C for
10min. PCRproductswere cloned into theTopo-XL cloning vector
according to manufacturer’s instructions (Invitrogen). Topo-XL
TABLE I. SNP Genotypes of the Proband
SNP Alleles Forward primer (50–30) Reverse primer (50–30) Proband
rs11117242 C/T CCAATGAGGTAAGCGCTGTT CAAGGGGACTGACTTTGGAA T/T
rs12598171 G/T TTTTTATGGGTTAGTATCTTGCTCA TGCAAGTCACTCACTATTCATAACTC T/T
rs17697644 A/G AAAATGACTGTGGGTCCTTCA ATGAGTAGGCTGCCCGTTTA A/G
rs4843530 A/G TTGAGCCATCCCCAAGTTAC GCATGTGCTCGTGGTAGAGA G/G
rs7196293 A/G GTGTTTCAGATGCCGGTGAC CACCCGTATGCTGTTGACC A/G
rs8056012 A/G GGTGTGAGCACCACAGGAG GATGGTGATGGTGACAATGG A/G
rs4843542 A/G ACATTTCCCCTCCGTAAAAA TTGGCTTAGAGAGCCTCCAG A/G
rs1465452 A/G TCCATCCTGTAAAGGCAACC GGCCAAGCCCATTTCTATTT A/G
rs6540015 C/G GTTCAAATCCTGCCTTGCTC TGGAATACGGGTGACAACAA G/–
rs4843223 C/T TACTCATGGCCAAGGAATGG TGCACACACAAGCACGTTTA C/–
rs12447701 C/G TTCATCAAATGCTCCCTGTG CATTTTGGTCTATTTGCTCTTGTT G/–
rs12711472 A/C GCCATCTGTAGGTGACAGCA AAAACACCCTCTAGGCAGCA C/–
rs4843556 C/T GGCAGGATGTAGCAGAAAGC TCAATTTCAGCATTGTTGGTG C/–
rs6540016 C/T CAGCCCTAGGATGATGGAAA GTGTTCCCCATCCACTTGTC T/–
rs8047567 C/G TGCACTTACCACAGCCAGAG TTTGCGTGAACCTCAGTTTG G/–
rs4843549 C/T GTCAGGCGTCTGGTACAGGT CCAAGAAGCAAGAGCAAACA T/–
rs4843547 A/C GCAGCTGTTAAAGTCTCTTGTCC TCTAGCCTGGGTGACAGAGC C/–
rs7499277 C/G TGAAGGGAAACTCAGGTGCT GGCCCAAGCCTCTCTCTTA G/–
rs11640181 A/G TCAGAAAAATGGCCACAACA CCCCTTGCTCAACTGTCATT A/–
rs4843576 C/T CAGGGAGGGAGAGCCAAG ATGCTACCAGCCTCCAGAAA T/–
rs1966575 A/G AAGGAAAAGGAGGGAAGCAG CTTCAAAGGAGGTGCAGAGC A/–
rs7195872 A/G TGCAATGGATAAGTCCAGATT CCTCTTGCCCAAGTTCACTG A/–
rs3748391 G/T TTATGTGCTGAGTGGGTGGA CTACCTGCCCGAGAGAGAAG T/–
rs9308346 A/T ATCTGCAGCTCCCAGCTTTA CCTTTCCTCCCCGGATAGT T/–
rs6540031 C/T ACCCCCAGAGCTTGTTCTCT CTCCCAAAGTGCTGGGACTA C/–
rs889602 C/G AGGGACAGGGACACACAGAG CAGCCCTACCAGCTGAACTC G/–
rs933717 C/T TGTCCAGGATCTCACAGCAG GCAGTTCCTCAAGTGGGATT C/–
rs9938881 A/C AGCCACACTCATCACCACAG CCAAGCAACACTGACTGCTC C/–
rs9927125 C/T GGAGAAACTCCAAAACAGCAA GACTTGGCTGCAGAGTTTCA T/–
rs4843612 A/G TTTATTACCAGATAGTCCCTCAAGC AAAATTAGTTTTCCCTCAACAATCA G/A
rs4843613 C/T GCCCCCACTGTAAGTTGAAA ACAGTCTGTGGCCTTTCCTG T/C
rs4843242 C/G AGCCTCTCCCTCAGAGCTTC TGTTGAGATTGGGTTGTTGG G/C
rs7205226 C/T GCCTTTTCTGCTAGCTGCTC CCCACCTGACCCATAAACAG C/T
rs9928618 C/G CCCCCAGCATGTAGGAAGT AAGCCCGAACCCTAACCTAA G/G
rs8056477 C/T ATCGCAGGGGAGTACTTGG CTTCCCTTTGATTCCCACAG C/T
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clones were end sequenced withM13Forward and Reverse primers
by the University ofMichiganDNA Sequencing Core. The deletion
breakpoints were conﬁrmed by PCR ampliﬁcation across the
breakpoint junction in amultiplex-PCR reaction that also included
ampliﬁcation of the wild type allele. Genomic DNA was ampliﬁed
by PCR using standard conditions with oligos Wt-F (50-AGCTCT-
AAAGTCCCCGAAGC-30), Brkpt-R (50-AGCCATCAGTGACCC-
CAGT-30), Wt-R (50-ACCGGTGCTTACTCTGAACG-30), an
annealing temperature of 65C and an extension time of 1min
for 35 cycles.
Copy Number Variation (CNV)
The Database of Genomic Variants (http://projects.tcag.ca/
variation/) was used to identify copy number variants in the
16q24.3 region.
RESULTS
Clinical Findings
The proband (Fig. 1, III-2) was ﬁrst seen at the University of
Michigan at the age of 10 years and 2.5 months and was referred
for evaluation of a possible vascular malformation syndrome and
developmental delay. She was born at term after an uncomplicated
pregnancy and weighed 2,325 g. Vascular malformations were
noted at birth involving the right parietal area, upper left chest,
left shoulder, left hand, and left leg. Bayley Scales of Infant Devel-
opment II testing at 32 months resulted in a mental development
index below 50 and an overall developmental age of 19 months.
Receptive and expressive communication skills were at the 24-
month level. The proband had a history of tympanostomy tube
placement at 2 years of age followed by normal tympanograms and
normal speech recognition threshold hearing testing. In the ﬁrst 3
years, she required casting for positioning of the left foot followed
by heel cord release surgery. Subsequently, at 12 years, she had right
equinus contracture requiring heel cord lengthening surgery. Past
medical history also includes diagnoses of attention deﬁcit hyper-
activity disorder, learning disabilities, mild intellectual im-
pairment, and recurrent urinary tract infections with bilateral
grade IV vesicoureteral reﬂux requiring bilateral ureteral reimplan-
tation surgery. Theproband’smother (Fig. 1, II-2) alsohadahistory
of mental impairment and learning problems, which required
special education services in school (formal testing was not
performed). The proband, her mother and her maternal grand-
mother reported recurrent eye irritation due to the inward growth
of eyelashes, which they treated themselves by eyelash removal
(Fig. 1, III-2, II-2, I-2, respectively). Furthermore, an extensive
family history of eye irritation and eyelash removalwas reported for
the maternal side of the family (Fig. 1, individuals III-3, III-4, II-2,
II-4 and siblings of I-2 not shown inpedigree). A full brother (Fig. 1,
III-1) was unaffected by any of these aforementioned clinical
conditions as veriﬁed by physical examination.
Physical examination of the proband showed microcephaly,
with a head circumference measuring 48.9 cm (<5%). An addi-
tional row of small eyelashes and pits from eyelash removal were
apparent upon visual examination of the patient, her mother and
maternal grandmother (data not shown). In addition to distichia-
sis, vascular anomalies were apparent in the proband and are
pictured in Figure 2A–F. The features of each lesion are described
in Table II. The vascular anomalies were congenital and became
more prominent with age. Some were macular (left chest, upper
scalp) with blue and red colored vessels; others were deep blue,
raised and soft in character. A skin biopsywas not obtained. An area
of cutis aplasia was detected on the scalp to the left of the sagittal
midline (10 2 cm2) and was discolored by a macular vascular
anomaly. Signiﬁcantly, no vascular lesions were detected in the oral
mucosa. Palpation of the lesions did not cause overt pain or
blanching.No cleft lip or palate nor dental anomalieswere detected.
No lymphedema was observed in the proband or other family
members. Renal ultrasound and echocardiogram revealed normal
anatomy. Magnetic resonance imaging of the brain and skull
revealed a vascularmalformation of the right parietal scalp without
FIG. 1. Transmission of the phenotypes in the family of the proband. Three generations of the proband’s family are shown by pedigree. Each generation
has affected individuals indicating possible autosomal dominant inheritance of distichiasis and vascular malformations, but with variable
expressivity for vascular malformations. Symbols used in the pedigree are shown in the legend.
842 AMERICAN JOURNAL OF MEDICAL GENETICS PART A
intracranial involvement. Chest MRI revealed cutaneous and sub-
cutaneous vascular anomaly of the left mid and anterior chest
without intrathoracic extension. MRI of the left leg revealed an
inﬁltrative lesion (large arrows, Fig. 3A) mainly within the soleus
and ﬂexor hallucis longus muscles, sparing the overlying distal
medial gastrocnemius muscle and extending to the ankle. The
intramuscular lesion is subtle and similar in signal intensity to
the adjacent normalmusculature.Mild enhancement was observed
within the intramuscular lesion, which increased on later images
and on coronal images (Fig. 3C,E) the lesion appears composed of
small vascular-like channels. The lesion extends into the adjacent
subcutaneous fat (Fig. 3A–D, small arrows), and this subcutaneous
component also has the appearance of vascular-like channels.
The overall appearance is most consistent with a vascular lesion,
likely a VM. No histopathology was performed preventing exact
identiﬁcation of the ectatic vessels. Inheritance of the vascular
malformations is uncertain, but the maternal grandmother of
the proband had lower extremity varicosities and dilated superﬁcial
veins (Fig. 2,G), and the father (Fig. 1, II-1),whowasunavailable for
examination was reported by the maternal grandmother to have a
prominent, discolored venous mass on his leg, larger than that
observed in the proband. In addition, a similar legmass was present
in the paternal grandmother, who was also unavailable for
examination.
Clinical Testing
StandardG-banded chromosomes of the proband showed anormal
karyotype with no gross chromosomal abnormalities. Fragile X
DNA testingwas normal. Hereditary distichiasis can be inherited as
a prominent feature of LD (OMIM153400) and varicose veins are a
less penetrant clinical manifestation associated with LD [Mellor
et al., 2007]. Therefore, based on the presence of both distichiasis
and vascular malformations, FOXC2 was tested for mutations.
Sequencing of the single FOXC2 coding exon did not detect a
mutation (datanot shown). Likewise, FISHusingBACprobeRP11-
463O9 that spans the FOXC2 gene demonstrated that the genomic
region surrounding and including the FOXC2 region was not
deleted (Fig. 4). The genome of the proband was also analyzed
for copy number alterations by chromosomal BAC microarray
analysis (CMA). CMA detected a deletion of BAC clone RP11-
106D4 (Fig. 5), which is located 745 kb distal to the FOXC2 locus.
The RP11-106D4 deletion was also detected in the mother of the
proband (Fig. 1, II-2), but was absent in her unaffected brother
(Fig. 1, III-1).
Identiﬁcation of the 16q24.3 Deletion
Breakpoint Junction
FISH was performed to conﬁrm the 16q24.3 deletion in the
proband. A FISH probe generated from BAC clone RP11-178L8,
a clone that overlaps RP11-106D4, hybridized to only one copy of
chromosome 16 on metaphase chromosomes from the proband
conﬁrming the deletion (Fig. 5A,C). The size of the deletion was
FIG. 2. Vascular malformations. VMs of right lateral brow (A),
v-shaped reticular lesions on the left side of the chest extending
from the scapula to below the sternum (B), lesions along the left
arm (C), vascular malformations of the posterior lower left leg at
the level of knee (D), vascular malformations of the left ankle and
plantar surface of the foot (E), and lesions of the left second ﬁnger
(F). Prominent superﬁcial vasculature is exhibited in the left leg of
the maternal grandmother of the proband (G).
TABLE II. Qualitative Description of the Vascular Lesions of the
Proband
Lesion Color Texture Appearance
Scalp Purple; red Flat Spider-like
R. forehead Blue-purple Worm-like Prominent
L. forehead Blue Fleshy Punctate
Chest Purple-red Peau d’orange Prominent
Chest Blue Flat Macular
L. arm Blue-green Soft, ﬂeshy Prominent
L. 2nd ﬁnger Blue-green Soft, ﬂeshy Prominent
L. leg Blue-purple Soft Varicose,
prominent
Dorsum l.
foot
Blue-purple Soft Varicose,
prominent
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unknown due to the incomplete chromosome coverage of the BAC
array. Therefore, BAC clones ﬂanking RP11-106D4 and RP11-
178L8 were also used as FISH probes. Proximal BAC clone
RP11-235F18 and distal BAC clone RP11-482M8 both produced
hybridization signals on both homologs of chromosome16 roughly
deﬁning the size of the deletion (Fig. 5B,D). To further reﬁne the
extent of the deletion, SNP genotyping was utilized tomap a region
ofhomozygosity surrounding thedeletion. SNPgenotypes from the
16q24.3 deletion region are summarized in Table I. rs1465452 and
rs4843612were the closest heterozygous SNPs ﬂanking the deletion
proximally and distally, respectively (Table I; Fig. 5A). Thus,
rs1465452 and rs4843612 narrowed the 16q24.3 deletion to ap-
proximately 280 kb.
To exactly determine the deletion boundaries, inverse PCR
products were generated with primers distal to rs4843612, which
were cloned and sequenced to identify the deletion breakpoint
junction. Sequencing of one of the clones, MTB3-1-2, revealed the
sequence of the 16q24.3 deletion breakpoint junction. There were
2 bp of homology at the breakpoints or any regions of extended
homology in the 10 kb region ﬂanking the breakpoints. The proxi-
mal and distal breaks occurred in an imperfect CAGAGA repeat
sequence located at nucleotide positions 85,769,299 (NCBI Build
36) and in an old L1 retrotransposon (L1M2) at 86,034,334,
respectively (Fig. 6A). To conﬁrm the positions of the breakpoints,
genomic DNA isolated from a blood sample from the proband was
used toPCRamplify the breakpoint region inboth thewild type and
16q24.3deletionallele (Fig. 6B).ThemultiplexPCRassay generated
both expected sizes for the wild type and 16q24.3 deletion alleles in
the proband, whereas an unrelated control DNA generated PCR
product corresponding to the wild type allele only. The deletion
appears to result either from the simple ligation of proximal and
distal DNA double strand breaks, consistent with formation by
FIG. 3. MRI imaging of the vascular anomalies of the proband. An inﬁltrative lesion (large arrows) is seen mainly within the soleus and ﬂexor hallucis
longus muscles, sparing the overlying distal medial gastrocnemius muscle. On T1 weighting (A), the intramuscular lesion is subtle and similar in
signal intensity to the adjacent normal musculature. Scattered tiny areas of high signal may represent minimal fat within the lesion. On ﬂuid
sensitive sequences (B,D), the lesion is of high signal. After gadolinium is administered (C), there is mild enhancement within the intramuscular
lesion,which increases on later images (E). Best seen on the coronal images (D,E), the lesion appears composed of small vascular-like channels. The
lesion extends into the adjacent subcutaneous fat (A–D, small arrows). The subcutaneous component also has the appearance of vascular-like
channels. The overall appearance is most consistent with a vascular lesion, likely a VM. The abnormality extends to the ankle (D, double arrows).
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NHEJ or a template switching mechanism such as MMBIR and
not from non-allelic homologous recombination (Fig. 6A) [Lieber
et al., 2003; Hastings et al., 2009]. Identiﬁcation of the breakpoints
showed that the submicroscopic 16q24.3 deletion includes
265,046 bp of sequence (Fig. 6C). The genes for C16ORF95,
FBXO31 (F-box protein 31), and MAP1LC3B (microtubule-
associated protein 1 light chain 3 beta) and all but the ﬁrst exon
of the ZCCHC14 (zinc ﬁnger, CCHC domain containing 14) gene
are deleted. In addition to these genes, the 16q24.3 deletion removes
115 kb of a gene desert located between FOXF1/FOXC2/FOXL1
gene cluster and C16ORF95.
Three CNVs in the 16q24.3 deletion region have been identiﬁed
in the Database of Genomic Variants (Table III). Two of the three
CNVs (variation 4970 and 8283) include gains with no observed
deletion. The distal 8 kb of the 16q24.3 deletion overlaps with a
reported 168 kb deletion CNV, including the putative promoter
region and ﬁrst exon of ZCCHC14 [Wang et al., 2007]. Deletion of
the centromeric 257 kb of the 16q24.3 deletion has not been
detected in any reported CNV, or in any of>1,000 high-resolution
chromosomal microarray cases in the Michigan Medical Genetics
Laboratories at the University of Michigan to date (unpublished
results).
GLMN and TIE2 Mutation Analysis
Physical evaluation of the vascular lesions in the proband (Fig. 2;
Table II) suggested that these lesions may be GVMs. Most VMs
are sporadic, but hereditary VMCM and GVMs are caused by
mutations in TIE2 and GLMN, respectively [Vikkula et al., 1996;
Brouillard et al., 2002, 2005; Wouters et al., 2010]. Allele-speciﬁc
PCR demonstrated that the proband was heterozygous for the
previously reported 157delAAGAA mutation (data not shown),
FIG. 4. FOXC2 deletion screening. A: Diagramof the genomic insert of
BAC clone RP11-463O9 including the genes (gray boxes) and
intergenic distances (kilobases). Exon/intron structure ofMTHFSD
is not shown for simplicity. B: FISH using RP11-463O9 as probe
generated hybridization signals on both chromosome 16
homologs (white arrows) of the proband.
FIG. 5. Mapping of the 16q24 contiguous gene deletion. A: Physical map of the 16q24 region showing the proximity of the deletion with respect to
FOXC2. Genes are depicted by gray boxes ignoring exon/intron structure. The dashed lines show the relative position of a 612 kb segment extending
from BAC clone RP11-235F18 to RP11-482M8. Genes in this magniﬁed region are represented by arrows showing the direction of transcription for
each gene. BAC clones used for FISHare shown as gray (1 signal-deleted) and black (2 signals-present) lines. SNPs rs1465452and rs4843612SNPs
are marked by vertical black lines. B–D: FISH on metaphase chromosomes from the proband. FISH was performed with BAC clone RP11-235F18 (B),
RP11-178L8 (C), and RP11-482M8 (D). In panel C, RP11-264L1 (red) was co-hybridized with RP11-178L8 (green) as a control probe to mark each
chromosome 16. White arrows mark hybridization signals. The red arrow marks the chromosome 16 carrying the deletion demonstrated by the
absence of a green (RP11-178L8) hybridization signal (panel C).
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whereas mutations were not detected in TIE2 [Vikkula et al., 1996;
Brouillard et al., 2002]. Consequently, the vascular malformations
of the proband are indeed GVMs.
DISCUSSION
We have presented the clinical and genomic characterization of
an individual with distichiasis, microcephaly, mild intellectual
impairment, but without lymphedema, associated with an inher-
ited 16q24.3 deletion that includes the C16ORF95, FBXO31,
MAP1LC3B, and ZCCHC14 genes as well as 115 kb of a gene desert
TABLE III. CNV in 16q24.3 Deletion Region
Variation Location Size (kb) Gain Loss
4970 16: 85,906,951–86,092,333 185 3 0
4971 16: 86,025,064–86,192,948 167 1 8
114272 16: 85,945,085–86,000,336 2 0
FIG. 6. Cloning of the 16q24 deletion by inverse PCR. A: 16q24.3 deletion breakpoints. The genomic sequence surrounding the proximal and distal
breakpoints of the 16q24.3 deletion is shown above a sequencing chromatogram from the pMTB3-1-2 inverse PCR clone (deleted sequence is
shaded). UCSC genome browser coordinates are shown above the sequence. Breakpoints are indicated by red lines. Deleted sequence is shown in
lowercasewhereaspresent sequence is shown inuppercase. B: Conﬁrmation of 16q24deletion breakpoints. A common forward primer (*) proximal to
the 16q24 deletion in combination with reverse primers speciﬁc for the wild type allele (black) and the deletion allele (red) were used for PCR. The
proband (P) was heterozygous for the 16q24 deletion whereas an unrelated control (C) was homozygous for the wild type allele. A control PCR
reaction with no template was also performed (H). C: The 16q24 deletion removes C16ORF95, FBXO31, MAP1LC3B, and ZCCHC14 loci. The 16q24
region is shown as a black horizontal line with vertical lines representing exons and arrows showing the direction of the corresponding transcripts.
The 16q24 deletion is depicted below by a red line.
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distal to the FOXF1/FOXC2/FOXL1 loci. The uniqueness of this
case is illustrated by the ability to differentiate it from other
syndromes. Distichiasis, the anomalous growth of eyelashes
from the meibomian glands, can be inherited in LD. The absence
of both lymphedema and a FOXC2 coding mutation, as well as
absence of many of the other LD-associated features argues against
diagnoses of LD. Similarly, the presence of microcephaly, bilateral
grade IV vesicoureteral reﬂux, and intellectual impairment has not
been reported to be associated with LD [Erickson et al., 2001;
Finegold et al., 2001; Brice et al., 2002].
The proband was originally referred not only for developmental
delay and microcephaly, but also for evaluation of the vascular
anomalies noted in Figure 2 and Table II. Boon et al. [2004]
described criteria for the differentiation between VMs, CMVMs,
andGVMs.GVMshave a cobblestoned appearance ranging in color
from pink to purplish dark blue, consistent with characteristics of
the proband’s lesions. Mutation testing determined that the pro-
band is heterozygous for a deleteriousGLMNmutation resulting in
numerous VMs that grossly are consistent with congenital GVMs.
These VMs are distributed in many locations, although none were
present in the oralmucosa and they did not blanch upon palpation,
consistent with the characteristics of GVM. Although FOXC2
mutations have been associated with varicose veins, the presence
of theGLMNmutation and resulting GVMsmakes it impossible to
discern the effect of the 16q24.3 deletionupon the vasculature of the
proband [Ng et al., 2005; Mellor et al., 2007]. The patients of
Stankiewicz (D2, D5, andD8) carried larger deletions including the
region deleted here, and there was no apparent VMs described
although these patients had a myriad of congenital anomalies and
short lifespans making a direct comparison tenuous. The GLMN
mutation status of the mother and maternal grandmother is
unknown. The proband’s father (unavailable for examination)
was reported to have vascular anomalies similar to the proband,
albeit a larger area of involvement on the leg. Consequently, the
GLMN mutation most likely is responsible for vascular lesions of
the proband and may have been inherited from her father, but it is
uncertain whether the venous varicosities of other individuals on
the maternal side of the family can be attributed to a GLMN
mutation.
The absence of reports in the literature of 16q rearrangements
producing 16q24.2-16q24.3monosomy led to speculation that loss
of this region is not tolerated [Callen et al., 1993]. More recently,
Stankiewicz et al. [2009] have described individuals carrying large
deletions that include the 16q24.3 deletion that we have delineated
in this study. Two of these patients (designated D2 and D5) had
dilated renal pelvices and bilateral renal pelviectasis, respectively.
Similarly, our proband had bilateral grade IV vesicoureteral reﬂux
requiring bilateral ureteral reimplantation surgery. Taken together
these observations suggest that the 16q24.3 deletion may be re-
sponsible for the renal anomaly in the proband.
Haploinsufﬁciency of one or a combination of the genes removed
by the 16q24.3 deletion could cause the non-vascular phenotypic
features of the proband. ZCCHC14 encodes a completely uncharac-
terized zinc ﬁnger protein. The ﬁrst two exons and putative
promoter region of ZCCHC14 are deleted in a CNV (variation
4971, Database of Genomic Variants) in 8 of 95 normal control
samples arguing that haploinsufﬁciencyofZCCHC14does not have
a phenotypic consequence [Wang et al., 2007]. Like ZCCHC14,
C16ORF95, a recently annotated gene located centromeric to
FBXO31, has no known function limiting the speculation of its
role in the phenotypic features of the proband.
FBXO31 is an F-boxprotein that has been reported to function as
a tumor suppressor in breast cancer cell lines by associating with a
SCF (Skp1-Cdc53-F-box protein) ubiquitin complex to target
substrates for degradation to progress through the cell cycle;
however, no role in ocular, neural, or blood vascular development
has been reported [Kumar et al., 2005]. Recently, FBXO31 was
shown to target CYCLIND2 for degradation in response to DNA
damage [Santra et al., 2009].
MAP1LC3B is one of three genes (MAP1LC3A,MAP1LC3B, and
MAP1LC3C) in the human genome homologous to the ratMap1lc3
and yeast Apg8 genes, both of which function in autophagy [He
et al., 2003]. Conditional knockout ofAtg5 andAtg7has shown that
impairment of autophagy leads to neurodegeneration in mice
[Hara et al., 2006; Komatsu et al., 2006]. The accumulation of
autophagic vesicles has also been found in a number of human
neurodegenerative disorders including Parkinsonism and Hun-
tington disease [Shintani and Klionsky, 2004]. Whether
MAP1LC3B haploinsufﬁciency causes autophagic defects in
humans is unknown and untested, but Map1lc3b transcripts are
expressed in the central nervous system in mice during embryo-
genesis suggesting that MAP1LC3B is a candidate gene for the
intellectual disability in our patient [Cann et al., 2008].
There is no support for a role of any of the three deleted genes in
development of distichiasis. The relative proximity of the 16q24.3
deletion to the FOXC2 locus, and the fact that FOXC2 haploinsuf-
ﬁciency causes distichiasis, suggests the possibility that FOXC2may
be involved via deletion of long-range cis-regulatory element(s)
controlling FOXC2 expression. There are many examples for such
effects. A large non-coding region or ‘‘gene desert’’ spanning 747 kb
is located distally to the forkhead gene cluster that includes FOXF1,
FOXC2, and FOXL1. Conserved non-coding elements in gene
deserts have been shown to have enhancer function in transgenic
experiments [Nobrega et al., 2003]. Mapping the breakpoints of a
balanced translocation (Y;16) to this region in a congenital lymph-
edema patient led to identiﬁcation of FOXC2 mutations in LD
families [Erickson et al., 1995; Fang et al., 2000]. The chromosome
16 translocation breakpoint occurred 120 kb telomeric to the
FOXC2 locus suggesting that removal of chromosome 16 distal
to the breakpoint and/or the addition of the Y chromosome
disrupted FOXC2 expression. In our case, the 265 kb deletion is
located 609 kb telomeric to FOXC2 and removes 151 kb of the gene
desert. Therefore, the 16q24.3 deletion could remove cis regulatory
element(s) responsible for FOXC2 expression in the developing
eyelid, a site of normal Foxc2 expression during development
[Kaestner et al., 1996; Iida et al., 1997; Winnier et al., 1997;
Pressman et al., 2000; Dagenais et al., 2004].
In summary, we have precisely mapped a submicroscopic con-
tiguous gene deletion in chromosome 16q24.3 in an individualwith
distichiasis, microcephaly, bilateral grade IV vesicoureteral reﬂux,
and mild intellectual impairment, who also has congenital GVMs
caused by adeleteriousGLMN genemutation. The 16q24.3deletion
causes haploinsufﬁciency of four genes, C16ORF95, FBXO31,
MAP1LC3B, and ZCCHC14, and removes 115 kb of a gene desert
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distal to the forkhead gene cluster on chromosome 16. The non-
vascular phenotypic features of the proband may result from
haploinsufﬁciency of the deleted genes and/or by disruption of
regulation of FOXC2 or other nearby gene expression.
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